Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics.
about
Tricyclic antidepressant pharmacology and therapeutic drug interactions updatedDifferential Effects of Azithromycin, Doxycycline, and Cotrimoxazole in Ingested Blood on the Vectorial Capacity of Malaria MosquitoesTherapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobioticsInhibition of acid sphingomyelinase by tricyclic antidepressants and analogonsDifferential direct effects of cyclo-oxygenase-1/2 inhibition on proteoglycan turnover of human osteoarthritic cartilage: an in vitro studyAstemizole synergizes calcitriol antiproliferative activity by inhibiting CYP24A1 and upregulating VDR: a novel approach for breast cancer therapyQuantitative cross-species extrapolation between humans and fish: the case of the anti-depressant fluoxetineIdentification of drugs inducing phospholipidosis by novel in vitro dataThe Effects of Pharmacological Compounds on Beat Rate Variations in Human Long QT-Syndrome CardiomyocytesIdentification of novel antimicrobials using a live-animal infection modelComprehensive characterization of cytochrome P450 isozyme selectivity across chemical libraries.Candesartan induces a prolonged proangiogenic effect and augments endothelium-mediated neuroprotection after oxygen and glucose deprivation: role of vascular endothelial growth factors A and B.No Camphor Toxicity in Cambodian Infants.Effects of prolonged exposure to low dose metformin in thyroid cancer cell lines.Determination of drug toxicity using 3D spheroids constructed from an immortal human hepatocyte cell line.Computational opioid prescribing: a novel application of clinical pharmacokinetics.Antibiotics in ingested human blood affect the mosquito microbiota and capacity to transmit malaria.Prediction of phenprocoumon maintenance dose and phenprocoumon plasma concentration by genetic and non-genetic parameters.Development and Validation of a GC-MS Method for the Detection and Quantification of Clotiapine in Blood and Urine Specimens and Application to a Postmortem CaseModulating protein activity using tethered ligands with mutually exclusive binding sites.AT1 receptor antagonism is proangiogenic in the brain: BDNF a novel mediator.Effects of cardioactive drugs on human induced pluripotent stem cell derived long QT syndrome cardiomyocytesA defined synthetic substrate for serum-free culture of human stem cell derived cardiomyocytes with improved functional maturity identified using combinatorial materials microarrays.Quantitative Detection of Nucleoside Analogues by Multi-enzyme Biosensors using Time-Resolved Kinetic Measurements.Recent in vitro findings of negative inotropy of pantoprazole did not translate into clinically relevant effects on left ventricular function in healthy volunteers.Linking pharmacology to clinical reports: cyclobenzaprine and its possible association with serotonin syndromeConcurrent release of admixed antimicrobials and salicylic acid from salicylate-based poly(anhydride-esters).Methylphenidate for Treating ADHD: A Naturalistic Clinical Study of Methylphenidate Blood Concentrations in Children and Adults With Optimized Dosage.Drug repurposing screens and synergistic drug-combinations for infectious diseases.On the relationship between block of the cardiac Na⁺ channel and drug-induced prolongation of the QRS complex.hERG subunit composition determines differential drug sensitivity.Pramipexole Overdose Associated with Visual Hallucinations, Agitation and Myoclonus.Population pharmacokinetics of intramuscular droperidol in acutely agitated patients.Chemical inhibitors of Candida albicans hyphal morphogenesis target endocytosis.Inhibition of voltage-gated sodium channels by sumatriptan bioisosteres.Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria.
P2860
Q24564967-DB4626C9-14EE-417E-A741-3D501A431036Q26315272-4A37C7A9-AFBA-4BEA-9A90-5359A534A75CQ26849557-500C9A4A-8AF7-45C1-9A7D-585BF7E6F791Q26852322-A22AD21E-4B7E-49B0-A176-DC9B3F86A311Q28193949-2D55419E-5000-41C0-8318-89B8870DA844Q28483692-843511ED-8791-4C5C-A26F-48F2A06E56E7Q28543995-7A1BA8F0-728A-4C7F-946A-C78A3AB93D11Q30560958-188BD3FB-0D60-4C0A-AF14-E99E82B29E47Q30828413-C9EE3A02-DDFB-4C9F-921E-BFE4D718237BQ33248011-3669F22A-C155-400D-8F67-E0D3BA15D6A8Q33512310-9A991BD5-B985-460D-948F-A01BEC2F8F77Q33603639-04F6A195-3520-4A6C-B4A8-1B2EAEBDCD6BQ33606497-775B760E-2839-43A8-8CC9-7700BD9CE074Q33702357-C9D80C2E-5342-47D2-94D3-7C38C64527F9Q34264069-DFDC2AB3-374C-465C-9538-9ADAE8B786A1Q35084232-DB33D2F1-9B46-42CE-888A-9742010AAD91Q35114250-D5D033BD-AF83-4DB2-80D5-20C47A2DD3B9Q35795269-61ED7C81-72F8-43AC-BD37-9BB4E8DF473CQ35868798-DB514B27-CAAD-4091-BEE4-E6AB37B21DDCQ35916975-533D898F-80B1-41CD-9913-8770A8EB2294Q36573232-9826B3E9-9761-4C1A-9F96-E3158394F37FQ36632323-F34E3EC6-B3AE-4167-A889-EC4FF60E05E7Q36657749-BAD836E9-2112-41CD-8CF2-3497301CB837Q37080484-D5BA8098-B62F-49B8-B5C7-5E9CE87892FEQ37233904-3ECB8713-A88A-4150-AD89-2E743E8BD480Q37257186-2018ED2B-3EC2-4E7F-875E-FBDBE3DB69B3Q37399847-58243E4A-32AE-4D84-851A-86DAC1B2A8DFQ37685508-EE37AED4-C683-4397-B571-D19E39FCF46EQ38158092-C4B16A55-295D-4988-941A-66BB5D7FDAAAQ38464799-6D47BF3A-6F1C-4243-81EA-CA797045C614Q38649960-39AC82B4-0A0E-48E3-8874-E51F6BABA996Q38762150-5D624FDB-9C10-4D6D-B0ED-EF5D71BF7393Q39485121-607633E3-42D6-4830-8585-5E1A7C21F9BFQ40129265-EA6ABD34-F7B9-47B2-8D14-4111AA2F5035Q42035720-C0A708AF-226C-4EEB-9C80-6AABAA5C044EQ42848863-811FD568-52F9-41C0-B7AF-7B4D6E3FA86C
P2860
Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics.
@ast
Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics.
@en
type
label
Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics.
@ast
Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics.
@en
prefLabel
Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics.
@ast
Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics.
@en
P1433
P1476
Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics
@en
P2093
P304
P577
2003-07-01T00:00:00Z